Cargando…
Methylenetetrahydrofolate Reductase Polymorphisms and Risk of Acute Lymphoblastic Leukemia-Evidence from an updated meta-analysis including 35 studies
BACKGROUND: 5,10-methylenetetrahydrofolate reductase (MTHFR) variants, C677T and A1298C, have been reported to be associated with decreased risk of acute lymphoblastic leukemia (ALL). However, results derived from individually underpowered studies are conflicting. We carried out an updated meta-anal...
Autores principales: | Wang, Haigang, Wang, Jiali, Zhao, Lixia, Liu, Xinchun, Mi, Wenjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459788/ https://www.ncbi.nlm.nih.gov/pubmed/22943282 http://dx.doi.org/10.1186/1471-2350-13-77 |
Ejemplares similares
-
Thiopurine S-Methyltransferase and Methylenetetrahydrofolate Reductase Polymorphisms in Leukemia
por: KÜPELİ, Serhan
Publicado: (2015) -
Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and susceptibility to pediatric acute lymphoblastic leukemia in a German study population
por: Schnakenberg, Eckart, et al.
Publicado: (2005) -
Association between Methylenetetrahydrofolate Reductase (MTHFR) Gene Polymorphisms and Susceptibility to Childhood Acute Lymphoblastic Leukemia in an Iranian Population
por: Bahari, Gholamreza, et al.
Publicado: (2016) -
Methylenetetrahydrofolate Reductase Polymorphisms and Pregnancy Outcome
por: Turgal, Mert, et al.
Publicado: (2018) -
Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer
por: Campbell, Ian G, et al.
Publicado: (2002)